Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Sales | 6,654 | 5,431 | 4,964 | 4,426 | 3,748 |
| Cost of Goods | 3,880 | 3,070 | 2,800 | 2,740 | 0 |
| Gross Profit | -11,210 | 7,620 | 7,430 | 5,690 | 3,748 |
| Operating Expenses | 4,250 | 1,550 | 1,510 | 1,380 | 0 |
| Operating Income | -1,476 | 811 | 654 | 306 | 3,748 |
| Interest Expense | 20 | 0 | 0 | 130 | 0 |
| Other Income | 5,906 | 5,819 | 5,736 | 4,354 | 0 |
| Pre-tax Income | 4,410 | 6,630 | 6,390 | 4,530 | 3,748 |
| Income Tax | 1,620 | 2,480 | 2,390 | 1,700 | 0 |
| Net Income Continuous | 3,667 | 4,151 | 3,995 | 2,835 | 2,145 |
| Net Income | $3,667 | $4,151 | $3,995 | $2,835 | $2,145 |
| EPS Basic Total Ops | 0.13 | 0.16 | 0.16 | 0.12 | 0.11 |
| EPS Basic Continuous Ops | 0.13 | 0.16 | 0.15 | 0.12 | 0.10 |
| EPS Diluted Total Ops | 0.12 | 0.15 | 0.14 | 0.11 | 0.09 |
| EPS Diluted Continuous Ops | 0.12 | 0.14 | 0.14 | 0.11 | 0.09 |
| EBITDA(a) | $-856 | $1,221 | $1,074 | $676 | $3,748 |